Dr. Ari Meerson

A picture of Dr. Ari Meerson on a visit to a museum in Stockholm
Research Group Leader
PhD
Phone
972-54-6320771
972-4-6955014
Full CV (PDF)
microRNA; RNA; obesity; diabetes; cancer; gene expression; genomics
Research Interests:

The Meerson group studies the molecular and genomic basis of chronic diseases, with a special focus on the function of microRNAs, short RNA molecules that regulate gene expression and are involved in a variety of biological pathways.  Specifically, we are interested in:

1. MicroRNAs as a mechanistic link between metabolic disease, cancer, and other chronic diseases

2. Discovery of microRNA-based biomarkers of disease in body fluids

3. Transcriptomics of reproduction and development in vertebrates

4. Novel applications of Oxford Nanopore sequencing technology

 

CV

Education and Research:

2013-pres    MIGAL Galilee Research Institute, Kiryat Shmona, Israel. Head of Genomics lab.

2015-2022   University of Copenhagen, Denmark. Guest Researcher, BMI.

2009-2013   NIH/NIDDK (Phoenix), AZ, USA. Postdoctoral Fellow. 

2003-2008   Hebrew University, Jerusalem, Israel.  PhD program, Department of Biological Chemistry. PhD, 2009.

2001-2003   Feinberg Graduate School of the Weizmann Institute of Science, Rehovot, Israel. MSc program, Department of Molecular Cell Biology. MSc, 2004.

1999-2001   Hebrew University, Jerusalem, Israel. Faculty of Life Sciences. Honors Program. BSc 2002, cum laude, completed in 2 years; Dean’s list and scholarship.

 

Assay development:

2017-2021        Developed a qPCR-based genetic assay for establishing the sex of Russian sturgeon fish, for caviar aquaculture. The method is in commercial use by Caviar Galilee ltd. since 2021.

2017                 Developed a qRTPCR-based molecular assay for assessing maize late wilt disease (published)

 

Teaching and Mentoring:

2017-pres    Mentor to 1 PhD student, 4 MSc students, and 9 undergraduate students)

2017-pres    Tel Hai Academic College, Biotechnology Department. Teaching 6 courses: Developmental Genetics (starting 2017); microRNAs/RNA World (starting 2020); Evolution, and Molecular Genetics B (both starting 2021); Practical Workshop in Genomic Lab Methods, and Big Questions in the Life Sciences (both starting 2023). Approved for promotion to Senior Lecturer.

2018-pres    Tel Hai, Science Faculty. Supervisory committee member for 3 MSc students

2016-pres    Tel Hai, Excellence Center. Mentored 8 high school students

Scientific Publications

Changes in brain MicroRNAs contribute to cholinergic stress reactions

A. Meerson; L. Cacheaux; K. A. Goosens; R. M. Sapolsky; H. Soreq; D. Kaufer
Journal of Molecular Neuroscience 2010 Volume 40 Issue 01-??? Pages 47-55
2010

MicroRNA-132 Potentiates Cholinergic Anti-Inflammatory Signaling by Targeting Acetylcholinesterase

I. Shaked; A. Meerson; Y. Wolf; R. Avni; D. Greenberg; A. Gilboa-Geffen; H. Soreq
Immunity 2009 Volume 31 Issue 6 Pages 965-973
2009

MicroRNA-132 regulates brain to body anti-inflammatory signaling

Soreq H, Shaked I, Meerson A, Avni R, Greenberg D, Gilboa-Geffen A
J Neurochem 2009 Volume 110 Pages 15-15
2009

Regulation of Alternative Splicing by Psychological Stress

Flores L, Meerson A, Goosens KA, Sapolsky R, Soreq H, Kaufer D
Society For Neuroscience 2007 Annual Meeting
2007

MicroRNA modulation of megakaryoblast fate involves cholinergic signaling

C. Guimaraes-Sternberg; A. Meerson; I. Shaked; H. Soreq
Leukemia Research 2006 Volume 30 Issue 5 Pages 583-595
2006

Modulation of N-ethylmaleimide-sensitive factor activity upon amino acid deprivation

H. Shorer; N. Amar; A. Meerson; Z. Elazar
Journal of Biological Chemistry 2005 Volume 280 Issue 16 Pages 16219-16226
2005

p53 mediates density-dependent growth arrest

A. Meerson; M. Milyavsky; V. Rotter
FEBS Letters 2004 Volume 559 Issue 02-??? Pages 152-158
2004

Prolonged Culture of Telomerase-Immortalized Human Fibroblasts Leads to a Premalignant Phenotype

M. Milyavsky; I. Shats; N. Erez; X. Tang; S. Senderovich; A. Meerson; Y. Tabach; N. Goldfinger; D. Ginsberg; C. C. Harris; V. Rotter
Cancer Research 2003 Volume 63 Issue 21 Pages 7147-7157
2003